|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/25/21 Emmaus Life Sciences, Inc. 10-K 12/31/19 121:29M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.84M
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 45K
3: EX-4.1 Instrument Defining the Rights of Security Holders HTML 32K
4: EX-10.11 Material Contract HTML 38K
5: EX-10.12 Material Contract HTML 38K
6: EX-10.23 Material Contract HTML 49K
7: EX-10.25 Material Contract HTML 103K
8: EX-10.26 Material Contract HTML 39K
9: EX-10.27 Material Contract HTML 71K
10: EX-10.28 Material Contract HTML 75K
11: EX-10.29 Material Contract HTML 115K
12: EX-10.30 Material Contract HTML 49K
13: EX-10.33 Material Contract HTML 39K
14: EX-10.34 Material Contract HTML 149K
15: EX-10.35 Material Contract HTML 40K
16: EX-10.37 Material Contract HTML 45K
17: EX-21.1 Subsidiaries List HTML 31K
18: EX-31.1 Certification -- §302 - SOA'02 HTML 36K
19: EX-31.2 Certification -- §302 - SOA'02 HTML 36K
20: EX-32.1 Certification -- §906 - SOA'02 HTML 32K
27: R1 Document and Entity Information HTML 86K
28: R2 Consolidated Balance Sheets HTML 109K
29: R3 Consolidated Balance Sheets (Parenthetical) HTML 47K
30: R4 Consolidated Statements of Operations and HTML 100K
Comprehensive Loss
31: R5 Consolidated Statements of Changes in HTML 97K
Stockholders' Equity (Deficit)
32: R6 Consolidated Statements of Cash Flows HTML 150K
33: R7 Description of Business HTML 39K
34: R8 Summary of Significant Accounting Policies HTML 68K
35: R9 Restatement of Previously Issued Financial HTML 646K
Statements
36: R10 Revenues HTML 120K
37: R11 Selected Financial Statement Captions - Assets HTML 91K
38: R12 Investments HTML 120K
39: R13 Selected Financial Statement Captions - HTML 108K
Liabilities
40: R14 Notes Payable HTML 708K
41: R15 Stockholders' Deficit HTML 432K
42: R16 Income Taxes HTML 144K
43: R17 Leases HTML 65K
44: R18 Commitments and Contingencies HTML 37K
45: R19 Related Party Transactions HTML 489K
46: R20 Subsequent Events HTML 53K
47: R21 Quarterly Financial Statements (Unaudited) HTML 830K
48: R22 Summary of Significant Accounting Policies HTML 131K
(Policies)
49: R23 Restatement of Previously Issued Financial HTML 640K
Statements (Tables)
50: R24 Revenues (Tables) HTML 123K
51: R25 Selected Financial Statement Captions - Assets HTML 96K
(Tables)
52: R26 Investments (Tables) HTML 112K
53: R27 Selected Financial Statement Captions - HTML 109K
Liabilities (Tables)
54: R28 Notes Payable (Tables) HTML 756K
55: R29 Stockholders' Deficit (Tables) HTML 431K
56: R30 Income Taxes (Tables) HTML 146K
57: R31 Leases (Tables) HTML 64K
58: R32 Related Party Transactions (Tables) HTML 487K
59: R33 Subsequent Events (Tables) HTML 38K
60: R34 Quarterly Financial Statements (Unaudited) HTML 828K
(Tables)
61: R35 Description of Business (Details Narrative) HTML 48K
62: R36 Summary of Significant Accounting Policies HTML 56K
(Details Narrative)
63: R37 Restatement of Previously Issued Financial HTML 102K
Statements (Details Narrative)
64: R38 Restatement of Previously Issued Financial HTML 172K
Statements (Details 1)
65: R39 Restatement of Previously Issued Financial HTML 123K
Statements (Parenthetical) (Details 1)
66: R40 Restatement of Previously Issued Financial HTML 163K
Statements (Details 2)
67: R41 Restatement of Previously Issued Financial HTML 98K
Statements (Parenthetical) (Details 2)
68: R42 Restatement of Previously Issued Financial HTML 201K
Statements (Details 3)
69: R43 Restatement of Previously Issued Financial HTML 41K
Statements (Parenthetical) (Details 3)
70: R44 Revenues (Details) HTML 37K
71: R45 Revenues (Details 1) HTML 45K
72: R46 Revenues (Details 2) HTML 41K
73: R47 Revenues (Details Narrative) HTML 41K
74: R48 Selected Financial Statement Captions - Assets HTML 40K
(Details)
75: R49 Selected Financial Statement Captions - Assets HTML 37K
(Details 1)
76: R50 Selected Financial Statement Captions - Assets HTML 45K
(Details 2)
77: R51 Selected Financial Statement Captions - Assets HTML 32K
(Details Narrative)
78: R52 Investments (Details Narrative) HTML 85K
79: R53 Investments (Details 1) HTML 38K
80: R54 Investments (Details 2) HTML 59K
81: R55 Selected Financial Statement Captions - HTML 65K
Liabilities (Details)
82: R56 Selected Financial Statement Captions - HTML 39K
Liabilities (Details 1)
83: R57 Selected Financial Statement Captions - HTML 42K
Liabilities (Details Narrative)
84: R58 Notes Payable (Details) HTML 109K
85: R59 Notes Payable (Details 1) HTML 63K
86: R60 Notes Payable (Details 2) HTML 130K
87: R61 Notes Payable (Details Narrative) HTML 57K
88: R62 Notes Payable (Details 3) HTML 40K
89: R63 Notes Payable (Details 4) HTML 56K
90: R64 Stockholders' Deficit (Details Narrative) HTML 161K
91: R65 Stockholders' Deficit (Details) HTML 38K
92: R66 Stockholders' Deficit (Details 1) HTML 51K
93: R67 Stockholders' Deficit (Details 2) HTML 42K
94: R68 Stockholders' Deficit (Details 3) HTML 51K
95: R69 Stockholders' Deficit (Details 4) HTML 42K
96: R70 Stockholders' Deficit (Details 5) HTML 89K
97: R71 Stockholders' Deficit (Parenthetical) (Details 5) HTML 31K
98: R72 Stockholders' Deficit (Details 6) HTML 41K
99: R73 Stockholders' Deficit (Details 7) HTML 59K
100: R74 Income Taxes (Details) HTML 39K
101: R75 Income Taxes (Details 1) HTML 58K
102: R76 Income Taxes (Details 2) HTML 39K
103: R77 Income Taxes (Details Narrative) HTML 47K
104: R78 Income Taxes (Details 3) HTML 49K
105: R79 Leases (Details Narrative) HTML 66K
106: R80 Leases (Details) HTML 46K
107: R81 Leases (Details 1) HTML 45K
108: R82 Commitments and Contingencies (Details Narrative) HTML 71K
109: R83 Related Party Transactions (Details) HTML 133K
110: R84 Related Party Transactions (Details Narrative) HTML 36K
111: R85 Subsequent Events (Details) HTML 41K
112: R86 Subsequent Events (Details Narrative) HTML 143K
113: R87 Quarterly Financial Statements (Unaudited) HTML 162K
(Details 1)
114: R88 Quarterly Financial Statements (Unaudited) HTML 119K
(Parenthetical) (Details 1)
115: R89 Quarterly Financial Statements (Unaudited) HTML 173K
(Details 2)
116: R90 Quarterly Financial Statements (Unaudited) HTML 102K
(Parenthetical) (Details 2)
117: R91 Quarterly Financial Statements (Unaudited) HTML 193K
(Details 3)
118: R92 Quarterly Financial Statements (Unaudited) HTML 37K
(Details Narrative)
120: XML IDEA XML File -- Filing Summary XML 211K
119: EXCEL IDEA Workbook of Financial Reports XLSX 195K
21: EX-101.INS XBRL Instance -- emma-20191231 XML 9.60M
23: EX-101.CAL XBRL Calculations -- emma-20191231_cal XML 341K
24: EX-101.DEF XBRL Definitions -- emma-20191231_def XML 1.45M
25: EX-101.LAB XBRL Labels -- emma-20191231_lab XML 1.94M
26: EX-101.PRE XBRL Presentations -- emma-20191231_pre XML 2.05M
22: EX-101.SCH XBRL Schema -- emma-20191231 XSD 296K
121: ZIP XBRL Zipped Folder -- 0001564590-21-001977-xbrl Zip 385K
Exhibit 4.1
NUMBER EMM [LOGO] SHARES SPECIMEN COMMON STOCK INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE REVERSE FOR CERTAIN DEFINITIONS FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF $0.001 PAR VALUE EACH OF EMMAUS LIFE SCIENCES, INC.transferable on the books of the Corporation in person or by attorney upon surrender of this certificate duly endorsed or assigned. This certificate and the shares represented hereby are subject to the laws of the State of Delaware, and to the Certificate of Incorporation and Bylaws of the Corporation, as now or hereafter amended. This certificate is not valid until countersigned by the Transfer Agent. WITNESS the facsimile signatures of its duly authorized officers. DATED: SECRETARY CHAIRMAN
THE CORPORATION WILL FURNISH TO ANY STOCKHOLDER, UPON REQUEST AND WITHOUT CHARGE, A FULL STATEMENT OF THE DESIGNA TIONS, RELATIVE RIGHTS, PREFERENCES AND LIMITATIONS OF THE SHARES OF EACH CLASS AND SERIES AUTHORIZED TO BE ISSUED, SO FAR AS THE SAME HAVE BEEN DETERMINED, AND OF THE AUTHORITY, IF ANY, OF THE BOARD TO DIVIDE THE SHARES INTO CLASSES OR SERIES AND TO DETERMINE AND CHANGE THE RELATIVE RIGHTS, PREFERENCES AND LIMITATIONS OF ANY CLASS OR SERIES. SUCH REQUEST MAY BE MADE TO THE SECRETARY OF THE CORPORATION OR TO THE TRANSFER AGENT NAMED ON THIS CERTIFICATE. The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:TEN COM - as tenants in common TEN ENT - as tenants by the entireties JT TEN- as joint tenants with right of survivorship and not as tenants in common UNIF GIFT MIN ACT- . . .. ....... ..... Custodian.. ..... .... ... .. .. . . (Gust)(Minor) under Uniform Gifts to Minors Act.. .... .... .... .. (State) Additional abbreviations may also be used though not in the above list. For Value Received, hereby sell, assign and transfer unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE) Shares of the stock represented by the within Certificate, and do hereby irrevocably constitute and appoint Attorney to transfer the said stock on the books of the within named Corporation with full power of substitution in the premises. Dated Signature(s) Guaranteed NOTICE: THE SIGNATURE(S) TOTHISASSIGNMENT MUST CORRESPOND WITH THE NAME(S)AS WRITTEN UPON THE FACE OF THE CERTIFICATE, IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER.By The Signature(s) must be guaranteed by an eligible guarantor institution (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions with membership in an approved Signature Guarantee Medallion Program), pursuant to SEC Rule 17Ad-15. COLUMBIA PRINTING SERVICES, LLC- www.stockinformation.com
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/23 Emmaus Life Sciences, Inc. 10-K 12/31/22 88:18M Donnelley … Solutions/FA 3/31/22 Emmaus Life Sciences, Inc. 10-K 12/31/21 98:18M ActiveDisclosure/FA 12/30/21 Emmaus Life Sciences, Inc. S-8 12/30/21 6:155K EdgarAgents LLC/FA 8/10/21 Emmaus Life Sciences, Inc. 10-K/A 12/31/20 92:18M ActiveDisclosure/FA 5/04/21 Emmaus Life Sciences, Inc. 10-K 12/31/20 97:18M ActiveDisclosure/FA |